MedTrace Logo

Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control

NCT00701831 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 241

Last updated 2010-11-04

No results posted yet for this study

Summary

Primary objective:

* To observe the efficacy of the forced titration to reach good glycemic control in Lantus treated patients

Secondary objectives:

* To assess the forced titration on physician and patient satisfaction
* To evaluate the impact of training tools by means of patient profile

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DRUG

Insulin glargine

The dose is titrated according to patient needs

Sponsors & Collaborators

Principal Investigators

  • Zeynep Cetin · Sanofi

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00701831 on ClinicalTrials.gov